-
公开(公告)号:US07666879B2
公开(公告)日:2010-02-23
申请号:US11816416
申请日:2006-02-23
申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
IPC分类号: A01N43/42 , A61K31/44 , C07D471/02 , C07D491/02 , C07D498/02 , C07D513/02 , C07D515/02 , C07D401/00
CPC分类号: C07D471/04
摘要: The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
摘要翻译: 本发明提供了下式所示的VEGF-R2抑制剂的化合物:(I)和使用这些化合物的方法。
-
公开(公告)号:US20090227622A1
公开(公告)日:2009-09-10
申请号:US11816416
申请日:2006-02-23
申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander Mclean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Yip , Boyu Zhong
发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander Mclean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Yip , Boyu Zhong
IPC分类号: A61K31/437 , C07D471/04
CPC分类号: C07D471/04
摘要: The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
摘要翻译: 本发明提供了下式所示的VEGF-R2抑制剂的化合物:(I)和使用这些化合物的方法。
-
公开(公告)号:US20110294792A1
公开(公告)日:2011-12-01
申请号:US13206057
申请日:2011-08-09
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: A61K31/551 , A61P19/08 , C07D487/04
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
-
公开(公告)号:US20090105229A1
公开(公告)日:2009-04-23
申请号:US12333775
申请日:2008-12-12
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel
IPC分类号: A61K31/5517 , C07D487/16
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式I的激酶抑制剂。
-
公开(公告)号:US08058425B2
公开(公告)日:2011-11-15
申请号:US13100618
申请日:2011-05-04
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: A61P25/08 , A61K31/55 , C07D487/06
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式的激酶抑制剂。
-
公开(公告)号:US20110207721A1
公开(公告)日:2011-08-25
申请号:US13100618
申请日:2011-05-04
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: A61K31/5517 , C07D487/04 , A61P3/10 , A61P25/28
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式I的激酶抑制剂。
-
7.
公开(公告)号:US07405305B2
公开(公告)日:2008-07-29
申请号:US10506029
申请日:2003-03-05
申请人: Pamela Ann Albaugh , Jochen Ammenn , Timothy Paul Burkholder , Joshua Ryan Clayton , Scott Eugene Conner , Brian Eugene Cunningham , Thomas Albert Engler , Kelly Wayne Furness , James Robert Henry , Sushant Malhotra , Mark Joseph Tebbe , Guoxin Zhu , YiHong Li , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Pamela Ann Albaugh , Jochen Ammenn , Timothy Paul Burkholder , Joshua Ryan Clayton , Scott Eugene Conner , Brian Eugene Cunningham , Thomas Albert Engler , Kelly Wayne Furness , James Robert Henry , Sushant Malhotra , Mark Joseph Tebbe , Guoxin Zhu , YiHong Li , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: C07D209/12 , C07D207/24 , C07D211/06
CPC分类号: C07D451/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D471/04 , C07D491/04
摘要: The present invention provides kinase inhibitors of Formula (I)
摘要翻译: 本发明提供式(I)的激酶抑制剂,
-
8.
公开(公告)号:US08063212B2
公开(公告)日:2011-11-22
申请号:US12516251
申请日:2007-12-11
申请人: Harold Burns Brooks , Joyce Z. Crich , James Robert Henry , Hong-Yu Li , Jason Scott Sawyer , Yan Wang
发明人: Harold Burns Brooks , Joyce Z. Crich , James Robert Henry , Hong-Yu Li , Jason Scott Sawyer , Yan Wang
IPC分类号: C07D401/00
CPC分类号: C07D409/14
摘要: The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. Formula I wherein: R1 is aminomethyl, (C1-C3 alkyl)aminomethyl, di(C1-C2 alkyl)aminomethyl, N-ethyl-N-methyl-aminomethyl, 1-aminoethyl, 1-((C1-C2 alkyl)amino)-ethyl, 3,3,3-trifluoro-propylaminomethyl, ethynyl, 2-hydroxy-ethoxy, 2-hydroxyethylaminomethyl, 2-cyanoethylaminomethyl, morpholin-4-ylmethyl, methoxymethoxymethyl, cyclopropyl, 1-azetidinylmethyl, 1-pyrrolidinylmethyl, or 1,3-dioxolan-2-yl; R2 is hydrogen or halo; R3 is hydrogen or halo; provided that at least one of R2 and R3 is hydrogen; R4 is hydrogen, methyl, or halo; and is a single bond that is either present or absent, or pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供了被认为具有通过抑制Plk1治疗癌症的临床用途的新型咪唑烷基氨基嘧啶化合物。 式(I)其中:R1是氨基甲基,(C1-C3烷基)氨基甲基,二(C1-C2烷基)氨基甲基,N-乙基-N-甲基 - 氨基甲基,1-氨基乙基,1-((C1-C2烷基)氨基) 乙基,3,3,3-三氟 - 丙氨基甲基,乙炔基,2-羟基 - 乙氧基,2-羟乙基氨基甲基,2-氰乙基氨基甲基,吗啉-4-基甲基,甲氧基甲氧基甲基,环丙基,1-氮杂环丁基甲基,1-吡咯烷基甲基, 3-二氧戊环-2-基; R2是氢或卤素; R3是氢或卤素; R2和R3中的至少一个是氢; R4是氢,甲基或卤素; 并且是存在或不存在的单键或其药学上可接受的盐。
-
9.
公开(公告)号:US08101628B2
公开(公告)日:2012-01-24
申请号:US12516514
申请日:2007-12-11
申请人: Harold Burns Brooks , Joyce Z. Crich , James Robert Henry , Hong-Yu Li , Melissa Kate Slater , Yan Wang
发明人: Harold Burns Brooks , Joyce Z. Crich , James Robert Henry , Hong-Yu Li , Melissa Kate Slater , Yan Wang
IPC分类号: C07D401/00
CPC分类号: C07D409/14
摘要: The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. wherein: R1 hydrogen, hydroxy, halo, methyl, C1-C2 alkoxy, amino, or methylamino; R2 is hydrogen, halo, or cyano; R3 is hydrogen or halo; R4 is hydrogen, halo, or methyl; provided that at least two of R1, R2, R3, and R4 are hydrogen; R5 is hydrogen, halo, or methyl; or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供了被认为具有通过抑制Plk1治疗癌症的临床用途的新型咪唑烷基氨基嘧啶化合物。 其中:R 1氢,羟基,卤素,甲基,C 1 -C 2烷氧基,氨基或甲基氨基; R2是氢,卤素或氰基; R3是氢或卤素; R4是氢,卤素或甲基; 条件是R 1,R 2,R 3和R 4中的至少两个为氢; R5是氢,卤素或甲基; 或其药学上可接受的盐。
-
10.
公开(公告)号:US20100076001A1
公开(公告)日:2010-03-25
申请号:US12516514
申请日:2007-12-11
申请人: Harold Burns Brooks , Joyce Z. Crich , James Robert Henry , Hong-Yu Li , Melissa Kate Slater , Yan Wang
发明人: Harold Burns Brooks , Joyce Z. Crich , James Robert Henry , Hong-Yu Li , Melissa Kate Slater , Yan Wang
IPC分类号: A61K31/506 , C07D409/14 , A61P35/04
CPC分类号: C07D409/14
摘要: The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. wherein: R1 hydrogen, hydroxy, halo, methyl, C1-C2 alkoxy, amino, or methylamino; R2 is hydrogen, halo, or cyano; R3 is hydrogen or halo; R4 is hydrogen, halo, or methyl; provided that at least two of R1, R2, R3, and R4 are hydrogen; R5 is hydrogen, halo, or methyl; or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供了被认为具有通过抑制Plk1治疗癌症的临床用途的新的咪唑烷基氨基嘧啶化合物。 其中:R 1氢,羟基,卤素,甲基,C 1 -C 2烷氧基,氨基或甲基氨基; R2是氢,卤素或氰基; R3是氢或卤素; R4是氢,卤素或甲基; 条件是R 1,R 2,R 3和R 4中的至少两个为氢; R5是氢,卤素或甲基; 或其药学上可接受的盐。
-
-
-
-
-
-
-
-
-